Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery

NCT01197664 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to funding issues

Conditions

Mucinous Adenocarcinoma of the Rectum
Stage IIA Rectal Cancer
Stage IIB Rectal Cancer
Stage IIC Rectal Cancer
Stage IIIB Rectal Cancer
Stage IIIC Rectal Cancer

Interventions

DRUG: paricalcitol
RADIATION: radiation therapy
OTHER: laboratory biomarker analysis
DRUG: fluorouracil

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]